survivin

Open Access
The Novel Use of IL-28 as an Effective Radiosensitizer in Pancreatic Cancer
XUHUI CHEN, HAYDEN Y. LEE, TRIEN T. TANG, CHENGLU QIN, SAMUEL A. PRISSEL, CHRISTIAN J. NELSON, LUKE A. SMITH, HUAPING XIAO, QIAN BAI, MICHAEL B. NICHOLL, MARK R. WAKEFIELD and YUJIANG FANG

Anticancer Research May 2023, 43 (5) 1885-1890; DOI: https://doi.org/10.21873/anticanres.16347
Open Access
Lurasidone Sensitizes Cancer Cells to Osimertinib by Inducing Autophagy and Reduction of Survivin
SHUHEI SUZUKI, MASAHIRO YAMAMOTO, TOMOMI SANOMACHI, KEITA TOGASHI, SHIZUKA SEINO, ASUKA SUGAI, TAKASHI YOSHIOKA, MASASHI OKADA and CHIFUMI KITANAKA

Anticancer Research September 2021, 41 (9) 4321-4331; DOI: https://doi.org/10.21873/anticanres.15237
You have access
YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression
TAKESHI MIYAO, HIDEKAZU KOIKE, YOSHITAKA SEKINE, AKIRA OHTSU, DAISUKE OKA and KAZUHIRO SUZUKI

Anticancer Research September 2020, 40 (9) 5091-5095; DOI: https://doi.org/10.21873/anticanres.14512
You have access
Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer
TOMOMI SANOMACHI, SHUHEI SUZUKI, KEITA TOGASHI, SHIZUKA SEINO, TAKASHI YOSHIOKA, CHIFUMI KITANAKA, MASASHI OKADA and MASAHIRO YAMAMOTO

Anticancer Research September 2019, 39 (9) 4817-4828; DOI: https://doi.org/10.21873/anticanres.13667
You have access
Down-regulation of Survivin by BIX-01294 Pretreatment Overcomes Resistance of Hepatocellular Carcinoma Cells to TRAIL
YENA NAMGUNG, SO YOUNG KIM and INKI KIM

Anticancer Research July 2019, 39 (7) 3571-3578; DOI: https://doi.org/10.21873/anticanres.13503
You have access
Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial–Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy
JIYOUNG KIM, SOOMIN AHN, KYUBO KIM, MIN SUN CHO, KWANG HO KIM, RYUNG-AH LEE and EUN MI NAM

Anticancer Research December 2018, 38 (12) 6881-6889; DOI: https://doi.org/10.21873/anticanres.13064
You have access
Investigation of Survivin Gene Polymorphism and Serum Survivin Levels in Patients with Brain Tumors
DIDEM KAFADAR, ILHAN YAYLIM, ALI METIN KAFADAR, CANAN CACINA, ARZU ERGEN, MEHMET YASAR KAYNAR and TURGAY ISBIR

Anticancer Research October 2018, 38 (10) 5991-5998; DOI: https://doi.org/10.21873/anticanres.12947
You have access
Inhibition of Survivin by Adenovirus Vector Enhanced Paclitaxel-induced Apoptosis in Breast Cancer Cells
TOSHIHIRO TANAKA and HIROAKI UCHIDA

Anticancer Research July 2018, 38 (7) 4281-4288; DOI: https://doi.org/10.21873/anticanres.12725
You have access
Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin
YOON JUNG KIM, HYO-JEONG HWANG, JUN GOO KANG, CHUL SIK KIM, SUNG-HEE IHM, MOON GI CHOI and SEONG JIN LEE

Anticancer Research June 2018, 38 (6) 3515-3525; DOI: https://doi.org/10.21873/anticanres.12623
You have access
Micropapillary Structures in Colorectal Cancer: An Anoikis-resistant Subpopulation
MADHURA PATANKAR, SARA VÄYRYNEN, ANNE TUOMISTO, MARKUS MÄKINEN, SINIKKA ESKELINEN and TUOMO J. KARTTUNEN

Anticancer Research May 2018, 38 (5) 2915-2921;

Main menu

User menu

Search

survivin

Pages